Gefitinib (ZD1839) increases the efficacy of cisplatin in ovarian cancer cells

Tsuyoshi Ohta(Yamagata University), Hirohisa Kurachi(Osaka Women's and Children's Hospital), Toshifumi Takahashi(Fukushima Medical University), Kazuhiro Takahashi, Masahide Ohmichi(Osaka University of Pharmaceutical Sciences), Seiji Tsutsumi(Yamagata University), Tae Shibuya(Yamagata University)

Cancer Biology & Therapy

April 1, 2012

10.4161/cbt.19292

Cited by 19

Related Papers

Estrogen Induces the Akt-dependent Activation of Endothelial Nitric-oxide Synthase in Vascular Endothelial Cells

|Journal of Biological Chemistry|2001|387

Inhibition of BAD phosphorylation either at serine 112 via extracellular signal-regulated protein kinase cascade or at serine 136 via Akt cascade sensitizes human ovarian cancer cells to cisplatin.

|PubMed|2000|249

Exosomes Promote Ovarian Cancer Cell Invasion through Transfer of CD44 to Peritoneal Mesothelial Cells

|Molecular Cancer Research|2016|232

A Physiological Role of Epidermal Growth Factor in Male Reproductive Function

|Science|1986|222

Inhibition of NFκB Increases the Efficacy of Cisplatin in in Vitro and in Vivo Ovarian Cancer Models

|Journal of Biological Chemistry|2004|212